Bigul

Symbiox Investment & Trading Company Ltd - 539278 - Closure of Trading Window

Dear Sir/Madam, Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended and clarification given by BSE vide circular no. LIST/COMP/01/2019-20 dated April 02, 2019 regarding trading restriction period and in accordance with the Company''s Code of Conduct for Prevention of 0Insider Trading, the Trading Window for dealing in the securities of the Company by 'Designated Persons' will remain closed with immediate effect till 48 hours of the declaration of Financial Results of the Company for the quarter ended June 30, 2019.
16-07-2019
Bigul

Symbiox Investment & Trading Company Ltd - 539278 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Please find enclosed statement showing the details of Demat/ Remat made in the quarter ended 30th June, 2019, received from ABS Consultant Pvt. Ltd., Registrar and Share Transfer Agent (RTA) of the company.
16-07-2019
Bigul

Symbiox Investment & Trading Company Ltd - 539278 - Statement Of Investor Complaints For The Quarter Ended June 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- NEHA PANSARIDesignation :- Company Secretary and Compliance Officer
11-07-2019
Bigul

Symbiox Investment & Trading Company Ltd - 539278 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dear Sir/Madam Please find enclosed statement showing the details of Demat/ Remat made in the quarter and year ended 31st March, 2019, received from ABS Consultant Pvt. Ltd., Registrar and Share Transfer Agent (RTA) of the company. Kindly take the above information on record
31-05-2019
Bigul

Symbiox Investment & Trading Company Ltd - 539278 - RESULTS- FINANCIAL RESULTS FOR THE YEAR 2018-19.

This is to inform you that Pursuant to Regulation 33 of SEBI (Listing Obligation & Disclosure Requirement) Regulation 2015, the Board of Directors of the company at their meeting held on 30th May, 2019, have approved the Audited Financial Results of the company for the quarter and year ended 31st March, 2019.
30-05-2019
Bigul

Symbiox Investment & Trading Company Ltd - 539278 - Outcome of Board Meeting

We would like to inform you that the Meeting of Board of Directors of Symbiox Investment & Trading Co Ltd was held on 30th May, 2019 Thursday at 03:00 P.M. at its registered office address
30-05-2019
Bigul

Symbiox Investment & Trading Company Ltd - 539278 - Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report27/05/2019 3 Name of the Certifying Firm AKHIL AGARWAL 4 Name of the Certifying Individual AKHIL AGARWAL 5Membership TypeACS 6 Membership Number 35073 7 CP No. 16313 8 Whether any observations/qualification reported by the Secretarial Auditor ? NO
28-05-2019
Bigul

Symbiox Investment & Trading Company Ltd - 539278 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompaySymbiox Investment & Trading Company Ltd 2CINL65993WB1979PLC032012 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NIL 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: NEHAPANSARI Designation: COMPANYSECRETARY EmailId: SYMBIOXINVESTMENT100@GMAIL.COM Name of the Chief Financial Officer: MOHIT SHARMA Designation: Chief Financial Officer EmailId: SYMBIOXINVESTMENT100@GMAIL.COM Date: 24/05/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
24-05-2019
Bigul

Symbiox Investment & Trading Company Ltd - 539278 - Board Meeting Intimation for Subject: Notice Of 03/19-20 Board Meeting To Be Held On 30Th May, 2019

Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2019 ,inter alia, to consider and approve Dear Sir, We would like to inform you that the meeting of Board of Director of Symbiox Investment & Trading Co ltd scheduled to be held on so" May, 2019, Thursday at 03.00 P.M at Registered Office of the Company to lnter-alia transact the following Matters: l. Pursuant to Regulation 33 of SEBI (Listing Obligation & Disclosure Requirement) Regulation 2015 consider and approve Audited Financial Result for Quarter and Year ended on 315t March, 2019. 2. To consider and approve the Auditor''s Report on the Financial Results for the quarter and Year ended on 31st March, 2019. L 3. To approve and reappoint M/s. Prakash Patwari & Co. Chartered Accountant as internal Auditor of the Company. 4. Any other matter with the permission of the Chairperson.
24-05-2019
Next Page
Close

Let's Open Free Demat Account